Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience

ABSTRACT: Background: Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatments. In that sense, we aimed to describe...

Full description

Autores:

Sánchez Caraballo, Jorge Mario
Londoño, Julián
Moreno López, Sergio Mauricio
Chapman, Edgardo
García Paba, María Beatriz
Celis, Ana María
Muñoz, María Angélica
Castillo Molina, David Alfredo
Arévalo Montenegro, Yaicith Cecilia
Lozano Mendoza, Ana Milena
Alvis Zakzuk, Nelson J.
Muñoz Mejía, César Andrés
Botero, Laura
Beltrán Sarmiento, Catalina
García Gómez, Elizabeth
Pérez Herrera, Lucía C.

Tipo de recurso:

Article of investigation

Fecha de publicación:

2023

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/44798

Acceso en línea:

https://hdl.handle.net/10495/44798

Palabra clave:

Dermatitis Atópica
Dermatitis, Atopic
Terapia Biológica
Biological Therapy
Eccema
Eczema
Enfermedades de la Piel
Skin Diseases
Dupilumab
https://id.nlm.nih.gov/mesh/D003876
https://id.nlm.nih.gov/mesh/D001691
https://id.nlm.nih.gov/mesh/D004485
https://id.nlm.nih.gov/mesh/D012871

Rights

openAccess

License

https://creativecommons.org/licenses/by-nc-nd/4.0/